Predicting Abnormal Coagulation in Ischemic Stroke: Reducing Delay in rt-PA Use
Neurol 67:1665-1667, Gottesman,R.F.,et al, 2006

Natural History of Human T-Lymphotropic Virus 1-Associated Myelopathy: A 14-Year Follow-Up Study
Arch Neurol 63:1560-1566, Olindo,S.,et al, 2006

Cost-Effectiveness of Recombinant Activated Factor VII in the Treatment of Intracerebral Hemorrhage
Stroke 37:2751-2758, Earnshaw,S.R.,et al, 2006

Seizures During Stroke Thrombolysis Heralding Dramatic Neurologic Recovery
Neurol 67:2048-2049, Rodan,L.H.,et al, 2006

Treatment and Prevention of Primary Intracerebral Hemorrhage
Semin Neurol 25:445-452, Towfighi,A.,et al, 2005

Protein S Deficiency in HIV Associated Ischaemic Stroke:An Epiphenomenon of HIV Infection
JNNP 76:1455-1456,1331, Mochan,A.,et al, 2005

Agressive Therapy With Intravenous Abciximab and Intra-Arterial rtPA and Additional PTA/Stenting Improves Clinical Outcome in Acute Vertebrobasilar Occlusion
Stroke 36:1160-1165, Eckert,B.,et al, 2005

Perfusion Computed Tomography: Prediction of Final Infarct Extent and Stroke Outcome
Ann Neurol 58:672-679,661, Parsons,M.W.,et al, 2005

Economic Benefit of Increasing Utilization of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in the United States
Stroke 36:2500-2503, Demaerschalk,B.M. &Yip,T.R., 2005

Poor Outcomes in Patients Who Do Not Receive Intravenous Tissue Plasminogen Activator Because of Mild or Improving Ischemic Stroke
Stroke 36:2497-2499, Smith,E.E.,et al, 2005

Outcome and Severe Hemorrhagic Complications of Intravenous Thrombolysis With Tissue Plasminogen Activator in Very Old (=80 Years) Stroke Patients
Stroke 36:2421-2425, Berrouschot,J.,et al, 2005

Clinical Importance of Microbleeds in Patients Receiving IV Thrombolysis
Neurol 65:1175-1178, Kakuda,W.,et al, 2005

Hemostatic Treatment in the Early Stage of Intracerebral Hemorrhage, The Recombinant Factor VIIa Experience
Stroke 36:2321-2322, Kase,C.S., 2005

Postinfection Myeloradiculoneuropathy With Cranial Nerve Involvements Associated With Human Herpesvirus 7 Infection
Arch Neurol 62:1735-1757, Mihara,T.,et al, 2005

Vertebrobasilar Disease
NEJM 352:2618-2626, Savitz,S.I.&Caplan,L.R., 2005

Time to Hospital Arrival, Use of Thrombolytics, and In-Hospital Outcomes in Ischemic Stroke
Neurol 64:2115-2120, Qureshi,A.I.,et al, 2005

Transcranial Low-Frequency Ultrasound-Mediated Thrombolysis in Brain Ischemia
Stroke 36:1441-1446, Daffertshofer,M.,et al, 2005

Houston Paramedic and Emergency Stroke Treatment and Outcomes Study (HoPSTO)
Stroke 36:1512-1518, Wojner-Alexandrov,A.,et al, 2005

Predictors of Early Arterial Reocclusion After Tissue Plasminogen Activator-Induced Recanalization in Acute Ischemic Stroke
Stroke 36:1452-1456, Rubiera,M.,et al, 2005

Ventriculitis and Hydrocephalus:An Unusual Presentation of Toxoplasmosis in an Adult with Human Immunodeficiency Virus
JNNP 76:1074, deSilva,T.,et al, 2005

CT and MRI Findings of Intracranial Lymphoma
AJR 184:1679-1685, Slone,H.W.,et al, 2005

Clinical Features of Status Epilepticus in Patients with HIV Infection
Neurol 65:314-316, Lee,K.C.,et al, 2005

Intravenous rt-PA for Acute Stroke: Comparing Its Effectiveness in Younger and Older Patients
JNNP 76:1234-1237, Mouradian,M.S.,et al, 2005

Clinical and Imaging Predictors of Intracerebral Haemorrhage in Stroke Patients Treated with Intravenous Tissue Plasminogen Activator
JNNP 76:70-75, Derex,I.,et al, 2005

MRI Screening Before Standard Tissue Plasminogen Activator Therapy Is Feasible and Safe
Stroke 36:1939-1943, Kang,D.-W.,et al, 2005

REACH Clinical Feasibility of a Rural Telestroke Network
Stroke 36:2018-2020, Hess,D.C.,et al, 2005

Lesion Size Determines Accuracy of Thallium-201 Brain Single-Photon Emission Tomography in Differentiating Between Intracranial Malignancy and Infection in AIDS Patients
AJNR 26:1973-1979, Younhg,R.J.,et al, 2005

Fatal Brain Necrosis in Primary HIV Infection
Lancet 366:866, Meersseman,W.,et al, 2005

tPA By Telephone: Extending the Benefits of a Comprehensive Stroke Center
Neurol 64:154-156, Frey,J.L.,et al, 2005

Telemedicine for Safe and Extended Use of Thrombolysis in Stroke
Stroke 36:287-291, Audebert, H.J., et al, 2005

Aggressive Mechanical Clot Disruption
Stroke 36:292-296, Noser, E.A., et al, 2005

Magnetic Resonance Imaging Criteria for Thrombolysis in Acute Cerebral Infarct
Stroke 36:388-397, Hjort, N., et al, 2005

Combined IV and intra-arterial thrombolysis for acute ischemic stroke
Neurol 64:386-388, Flaherty, M.L., et al, 2005

Do the Brain Attack Coalition's Criteria for Stroke Centers Improve Care for Ischemic Stroke?
Neurol 64:422-427, Douglas, V.C., et al, 2005

Intraocular Haemorrhage after Thrombolysis
Lancet 365:330, Kaba, R.A., et al, 2005

Safety and Efficacy of Intravenous Tissue Plasminogen Activator Stroke Treatment in the 3- to 6-Hour Window Using Multimodal Transcranial Doppler/MRI Selection Protocol
Stroke 36:602-606, Ribo,M., et al, 2005

Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
NEJM 352: 777-785, 828, Mayer, S.A., et al, 2005

Prioritizing interventions to Improve Rates of Thrombolysis for Ischemic Stroke
Neurol 64:654-659, California Acute Stroke Pilot Registry (CASPR) Inv, 2005

Reasons for Exclusion From Thrombolytic Therapy Following Acute Ischemic Stroke
Neurol 64:719-720, Cocho,D., et al, 2005

Unusual Variants of Alexander's Disease
Ann Neurol 57:327-338, van der Knaap,M.S., et al, 2005

Prospective Reliability of the Stroke Doc Wireless/Site Independent Telemedicine System
Neurol 64:1058-1060, Meyer,B.C., et al, 2005

Clinicopath Conf, Human Granulocytic Ehrlichiosis
NEJM 352:1358-1364, Case 10-2005, 2005

Guidelines for the Early Management of Patients with Ischemic Stroke
Stroke 36:916-921, Adams,H.,et al, 2005

Reversal of Warfarin-Induced Anticoagulation with Factor VIIa Prior to rt-PA in Acute Stroke
Neurol 64:1480-1481, Talkad,A.,et al, 2005

Autonomic Peripheral Neuropathy
Lancet 365:1259-1270, Freeman,R., 2005

Thrombolytic Therapy of Acute Ischemic Stroke: Correlation of Angiographic Recanalization with Clinical Outcome
AJNR 26:880-884, Zaidat,O.O.,et al, 2005

Cerebral MR Imaging in Uninfected Children Born to HIV-Seropositive Mothers and Perinatally Exposed to Zidovudine
AJNR 26:695-701,687, Tardieu,M.,et al, 2005

Thrombosis of the Cerebral VEins and Sinuses
NEJM 352:1791-1798, Stam,J., 2005

Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours
Stroke 36:1099-1100, 1100, Zivin,J.A., 2005

Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now Be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours
Stroke 36:1098-1099,1100, Schellinger,P.D. &Fiebach,J.B., 2005